Grannus Therapeutics’ Post

If your attending AACR stop by the Lead Identification and Optimization Poster session this morning (9-12:30) to learn about the exciting work Grannus has been doing on our First-in-Class Hsp90𝛽-selective inhibitor! Poster Number 1814

To view or add a comment, sign in

Explore topics